Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Cores

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Optometry and Vision Science : Official Publication of the American Academy of Optometry|November 6, 2015
Foster Kennedy Syndrome: An Atypical PresentationAlberto Parafita-Fernández, Marta Sampil, Carlos Cores, et al.
Practical Neurology|July 8, 2020
Protecting people with multiple sclerosis through vaccinationSaúl Reyes, Mary Ramsay, Shamez Ladhani, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 11, 2020
Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish PatientsDiego Santos-García, Mila Oreiro, Patricia Pérez, et al.
Journal of Personalized Medicine|August 27, 2021
Pain Improvement in Parkinson's Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR StudyDiego Santos García, Rosa Yáñez Baña, Carmen Labandeira Guerra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 23, 2021
Safinamide improves sleep and daytime sleepiness in Parkinson's disease: results from the SAFINONMOTOR studyDiego Santos García, Iria Cabo López, Carmen Labandeira Guerra, et al.
Brain Sciences|November 11, 2022
Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson's Disease Patients with Major Depression: An Open-Label Prospective StudyDiego Santos García, Maria Gema Alonso Losada, Icíar Cimas Hernando, et al.
Parkinsonism & Related Disorders|October 7, 2023
Response to levodopa in Parkinson's disease over time. A 4-year follow-up studyDiego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, et al.
Movement Disorders Clinical Practice|May 15, 2024
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up StudyDiego Santos-García, Teresa de Deus, Carlos Cores, et al.
Journal of Neurology|August 14, 2023
Cognitive impairment and dementia in young onset Parkinson's diseaseDiego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, et al.
Brain and Behavior|November 8, 2023
Staging Parkinson's disease according to the MNCD classification correlates with caregiver burdenDiego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Optometry and Vision Science : Official Publication of the American Academy of Optometry|November 6, 2015
Foster Kennedy Syndrome: An Atypical PresentationAlberto Parafita-Fernández, Marta Sampil, Carlos Cores, et al.
Practical Neurology|July 8, 2020
Protecting people with multiple sclerosis through vaccinationSaúl Reyes, Mary Ramsay, Shamez Ladhani, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 11, 2020
Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish PatientsDiego Santos-García, Mila Oreiro, Patricia Pérez, et al.
Journal of Personalized Medicine|August 27, 2021
Pain Improvement in Parkinson's Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR StudyDiego Santos García, Rosa Yáñez Baña, Carmen Labandeira Guerra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 23, 2021
Safinamide improves sleep and daytime sleepiness in Parkinson's disease: results from the SAFINONMOTOR studyDiego Santos García, Iria Cabo López, Carmen Labandeira Guerra, et al.
Brain Sciences|November 11, 2022
Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson's Disease Patients with Major Depression: An Open-Label Prospective StudyDiego Santos García, Maria Gema Alonso Losada, Icíar Cimas Hernando, et al.
Parkinsonism & Related Disorders|October 7, 2023
Response to levodopa in Parkinson's disease over time. A 4-year follow-up studyDiego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, et al.
Movement Disorders Clinical Practice|May 15, 2024
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up StudyDiego Santos-García, Teresa de Deus, Carlos Cores, et al.
Journal of Neurology|August 14, 2023
Cognitive impairment and dementia in young onset Parkinson's diseaseDiego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, et al.
Brain and Behavior|November 8, 2023
Staging Parkinson's disease according to the MNCD classification correlates with caregiver burdenDiego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, et al.
Pageof 3